Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CenraTPE:3716 -0.46%15 Pretax Margin % is 4.82% as of Dec. 2025, which is 1% below its 10-year median of 4.89. GuruFocus rates TPE:3716 with a GF Score™ of 15/100. The stock has 4 warning signs investors should review. Among 118 Medical Distribution companies, Cenra ranks better than 74.58% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Cenra's Pre-Tax Income for the
three
months ended in Dec. 2025 was NT$104 Mil. Cenra's Revenue for the
three
months ended in Dec. 2025 was NT$2,146 Mil. Therefore, Cenra's pretax margin for the quarter that ended in Dec. 2025 was 4.82%.
The historical rank and industry rank for Cenra's Pretax Margin % or its related term are showing as below:
TPE:3716'
s Pretax Margin % Range Over the Past 10 Years
Min: 4.33 Med: 4.89 Max: 8.29
Current: 4.89
TPE:3716's Pretax Margin % is ranked better than 74.58% of 118
companies
in the Medical Distribution industry
Industry Median: 2.245
vs TPE:3716: 4.89
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Cenra Pretax Margin % Related Terms
Cenra Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Cenra's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:3716 vs MCK, COR, CAH: Pretax Margin % Comparison
For the Medical Distribution subindustry, Cenra's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cenra Pretax Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cenra's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Cenra's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cenra (TPE:3716) has a Pretax Margin % of 4.82% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Cenra and its competitors. This is near median its historical median of 4.89. Over the past decade, Cenra's Pretax Margin % has ranged from 4.33 to 8.29. According to the industry distribution chart, Cenra ranks #30 out of 118 companies in the Medical Distribution industry, placing it in the top 25.4%.
Is Cenra's Pretax Margin % too high?
Cenra's current Pretax Margin % of 4.82% is near median its 10-year median of 4.89. Over the past 10 years, this metric has ranged from a low of 4.33 to a high of 8.29. The Medical Distribution industry median Pretax Margin % is 2.25. Cenra's value of 4.82% is 114.7% above this industry median. Based on the distribution chart, Cenra ranks #30 out of 118 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Cenra has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Cenra's Pretax Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Cenra ranks #30 out of 118 companies for Pretax Margin %. This puts Cenra in the upper half of its industry. The industry median Pretax Margin % is 2.25. Cenra's value of 4.82% is 114.7% above this benchmark. Historically, Cenra's own Pretax Margin % has ranged from 4.33 to 8.29 over the past decade. While the company's 10-year median is 4.89 vs. the industry median of 2.25, Cenra has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Distribution company?
The median Pretax Margin % among Medical Distribution companies is 2.25, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cenra's current Pretax Margin % of 4.82% is 114.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Cenra and its competitors. For the Medical Distribution industry, the median Pretax Margin % is 2.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cenra's current Pretax Margin % is 4.82%, which is near median its own 10-year median of 4.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cenra stock overvalued right now?
Cenra (TPE:3716) has a current Pretax Margin % of 4.82%. The current Pretax Margin % is 4.82%, which is near median its 10-year median of 4.89 and 114.7% above the Medical Distribution industry median of 2.25. Cenra's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Cenra (TPE:3716), the current Pretax Margin % is 4.82% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:3716 has been successfully added to your 
